Celera Hopes to Translate Genetic Heart Disease Research Into Diagnostic Tool

Jan 22, 2008

NEW YORK (GenomeWeb News) – Three soon-to-be published studies suggest that a polymorphism in KIF6, a gene encoding a kinesin-like protein in the molecular motor family, increases the risk of coronary heart disease, Celera announced yesterday.

Celera subsidiary Berkeley HeartLab is developing a laboratory test, which it expects to launch in the coming months, for the gene variant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu